The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Not sure why some of these updates had to be held back for an all in one quarterly RNS? Surely more consistent updates are exactly what shareholders need right now.
The language used regarding a potential sale are very noncommittal. “Consider options” is consistent in their loose wording around a sale, however “there can be no guarantee Eurasia will enter into binding agreements” sounds far from positive. I’m guessing no sale is on the cards so long as there are “geopolitical situations”.
Given the position we are in, and the SP, regular updates, even unsubstantial would put shareholders minds at ease (a little).
The longer the radio silence the more you expect bad news, or at best a regression in progress towards aims. It doesn’t make any sense for the BOD to be progressing behind the scenes and not keep shareholders up to speed.
Considered buying into this prior to the Science Day. I was totally bashed for suggesting these hyped up RNS’ are often non-events. I’d imagine a lot of PIs thought they’d be getting rich quick after that RNS dropped and are now getting out.
Still hoping to get in, I’ll wait and see what happens over the next 4-8 weeks. See where it bottoms out.
It may be a mess but some average to high to make it worthwhile selling their shares.
At this point, those invested surely have nothing but hope or delusion. Maybe it’s BRICS the BoD are focusing on, but even they won’t be encouraged by Putin and his one man mission to catastrophe.
I’m still in, I still have hope, but it’s based on nothing at this point.
It isn’t a premium though is it? It’s still a phase 1 trial drug, it’s been administered to a handful of people and is far from development. If it was ever to sell (my presumed outcome) it’d jump a lot more than after “science day”.
Posts like that are ill informed and speculative at best. I lm an investor, my gambling days are over.
Seems most AIM shares on this forum are full of tolls.
Been keeping an eye on this since October time, I’d like to invest in such a potentially ground breaking drug, but I’ve been stung a couple of times in later phase trials by these types of shares.
What’s this science day all about? Maybe I’ll get in following that, these events often turn out to be insignificant though.
Polly - I meant Premier African Minerals, I bought a loaf under 12p in 2021, sold at 27p and then topped up my EUA, which is proving a big mistake.
Del - I struggle to see anybody buying our assets in the current climate, surely the SP reflects this?
SOU was my first investment (gamble) in 2015, or 2016, got lucky and probably would never have invested again had it not worked out.
I’m don’t with AIM after this, I did okay out of PREM then topped up with that in here. Everything about EUA seemed (seems?) sound, but I’m growing wary with every passing RNS delivering nothing but promises.
Not really, I would assume if we run out of cash then we start digging metal.
I know we don’t even have DFS results yet, or a binding offer, and Russia are at war.
Do you expect much progress in the next 6 months?